Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. (Record no. 25743749)

MARC details
000 -LEADER
fixed length control field 01632 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517081517.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201612s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1745-6215
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1186/s13063-016-1220-9
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Sommerer, Claudia
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20161213
245 00 - TITLE STATEMENT
Title Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Trials
Date of publication, distribution, etc. Feb 2016
300 ## - PHYSICAL DESCRIPTION
Extent 92 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Protocols
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclosporine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Everolimus
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Graft Rejection
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Kidney Transplantation
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Outcome Assessment, Health Care
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Research Design
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tacrolimus
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Failure
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Suwelack, Barbara
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dragun, Duska
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schenker, Peter
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hauser, Ingeborg A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nashan, Björn
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Thaiss, Friedrich
773 0# - HOST ITEM ENTRY
Title Trials
Related parts vol. 17
-- p. 92
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1186/s13063-016-1220-9">https://doi.org/10.1186/s13063-016-1220-9</a>
Public note Available from publisher's website

No items available.